Showing results (1231-1240 of 1,896) with videos related to
Sort By:
Pageof 190
Journal of Neurophysiology|March 4, 2003
A temporally asymmetric Hebbian rule governing plasticity in the human motor cortexAlexander Wolters, Friedhelm Sandbrink, Antje Schlottmann, et al.Journal of Cancer Research and Clinical Oncology|July 8, 1999
Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomideF Paulsen, W Hoffmann, G Becker, et al.Deutsche Medizinische Wochenschrift (1946)|May 18, 1999
[Prospective Epidemiologic Study of Epigastric Discomfort (PRESTO). Ground work and preliminary results]H D Allescher, G Adler, J Hartung, et al.Molecular Human Reproduction|July 25, 2000
Modulation of endometrial transformation in gonadotrophin-stimulated and unstimulated pseudo-pregnant rabbits: studies with the progesterone receptor antagonist, onapristoneC A Krusche, A Herrler, I Classen-Linke, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 5, 2006
Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapyRainer Souchon, Ulrich Gertenbach, Klaus-Peter Dieckmann, et al.Brain Stimulation|April 13, 2025
Predictive role of endogenous phase lags between target brain regions in dual-site transcranial alternating current stimulationOsama Elyamany, Jona Iffland, Josef Bak, et al.The New England Journal of Medicine|January 12, 1989
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcerA Walan, J P Bader, M Classen, et al.Pharmacology Research & Perspectives|April 18, 2024
Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case reportCamilo Scherkl, Andreas D Meid, Sven E Cuntz, et al.Current Biology : CB|February 13, 2024
A mismatch in the expression of cell surface molecules induces tissue-intrinsic defense against aberrant cellsFriedericke Fischer, Laurin Ernst, Anna Frey, et al.Journal of Neural Transmission. Supplementum|January 1, 1990
Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorderG Laux, W Classen, E Sofic, et al.Pageof 190